Dimensional Fund Advisors’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.7M Buy
1,084,765
+38,071
+4% +$729K ﹤0.01% 2098
2026
Q2
$19.1M Buy
1,046,694
+140,666
+16% +$2.09M ﹤0.01% 2059
2026
Q1
$12.9M Buy
906,028
+57,259
+7% +$736K ﹤0.01% 2165
2025
Q4
$8.78M Sell
848,769
-335,052
-28% -$3.02M ﹤0.01% 2326
2025
Q3
$7.02M Sell
1,183,821
-92,717
-7% -$679K ﹤0.01% 2429
2025
Q2
$9.6M Sell
1,276,538
-26,683
-2% -$214K ﹤0.01% 2289
2025
Q1
$9.9M Sell
1,303,221
-15,151
-1% -$145K ﹤0.01% 2256
2024
Q4
$16.1M Buy
1,318,372
+295,467
+29% +$4.25M ﹤0.01% 2087
2024
Q3
$17.1M Buy
1,022,905
+263,145
+35% +$4.67M ﹤0.01% 2073
2024
Q2
$13.2M Sell
759,760
-233,617
-24% -$4.97M ﹤0.01% 2138
2024
Q1
$16.9M Buy
993,377
+77,619
+8% +$1.2M ﹤0.01% 2071
2023
Q4
$9.33M Buy
915,758
+117,042
+15% +$1.04M ﹤0.01% 2348
2023
Q3
$7.23M Buy
798,716
+276,049
+53% +$2.87M ﹤0.01% 2400
2023
Q2
$5.62M Buy
522,667
+176,448
+51% +$1.87M ﹤0.01% 2481
2023
Q1
$3.54M Buy
+346,219
New +$3.82M ﹤0.01% 2590
2022
Q3
$145K Buy
+11,284
New +$152K ﹤0.01% 3288

Other funds holding CGEM

Dimensional Fund Advisors's CGEM Position: Q3 2026 in Review

Dimensional Fund Advisors increased its Cullinan Oncology (CGEM) stake by 3.6% in Q3 2026, buying an estimated $729K and bringing the position to 1,084,765 shares worth $16.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2098.

Dimensional Fund Advisors first reported a position in CGEM in Q3 2022 and has held it in 16 quarters since. The position peaked at $19.1M in Q2 2026. 55 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.

  • Dimensional Fund Advisors held 1,084,765 shares of Cullinan Oncology worth $16.7M as of Q3 2026.
  • Dimensional Fund Advisors bought 38,071 Cullinan Oncology shares in Q3 2026, an estimated $729K.
  • Cullinan Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2098 holding.
  • Dimensional Fund Advisors first reported a position in Cullinan Oncology in Q3 2022 and has held it in 16 quarters since.
  • Dimensional Fund Advisors's Cullinan Oncology position peaked at $19.1M in Q2 2026.
  • 55 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.